Skip to content

Guide · Capital Markets and Securities

IPOs and Equity Offerings in Canada

Equity offerings in Canada range from first-time IPOs on the TSX or TSX Venture Exchange to overnight bought deals and at-the-market programmes for seasoned issuers. This page explains how each route works, the prospectus rules behind them, the liability that attaches to disclosure, and how foreign issuers use cross-border systems to raise equity in Canada.

10 min read Updated
ENFR

Key takeaways

  • A first-time IPO uses a long-form prospectus under NI 41-101, reviewed by the principal regulator.
  • Seasoned issuers can use short-form and shelf prospectuses, enabling bought deals and at-the-market sales.
  • Purchasers have a two-business-day withdrawal right and statutory rights of action for misrepresentation.
  • Eligible US issuers can offer in Canada using US documents under the multijurisdictional disclosure system.
  • Prospectuses for distributions in Quebec must generally be available in French.

How equity offerings work in Canada

Equity offerings in Canada are distributions of shares or units to investors, made either under a prospectus filed with the securities regulators or under an exemption. This page deals with public offerings: the initial public offering (IPO) through which a company first becomes a reporting issuer and lists its shares, and the follow-on offerings that listed companies use to raise more capital. Private placements are covered on our prospectus-exempt financings page.

Bell-ringing ceremony and prospectus for equity offerings on a Canadian stock exchange
Canadian public offerings combine regulator review, exchange approval and underwriter due diligence.

A prospectus must provide full, true and plain disclosure of all material facts about the securities offered. It is filed in each province and territory where the securities will be sold, reviewed by the issuer's principal regulator under the passport system, and receipted once comments are resolved. The issuer, its directors, its CEO and CFO, any promoters, the underwriters and certain experts are liable to purchasers for misrepresentations, subject to due diligence defences. That liability is the reason Canadian equity offerings involve extensive due diligence and carefully drafted disclosure.

Canada has three main venues for listing equity: the Toronto Stock Exchange (TSX) for established companies, the TSX Venture Exchange (TSXV) for earlier-stage companies, and the Canadian Securities Exchange (CSE). Each sets its own listing requirements, which vary by industry. Mining and energy companies, which make up a large share of Canadian listings, must also meet specialized technical disclosure standards. For the overall framework, see our capital markets overview.

The initial public offering

Preparing for an IPO

Preparation usually begins six months or more before launch. The company reorganizes its share capital into a public-company structure, converts preferred shares and other instruments, adopts public-company governance (an independent board and audit committee, insider trading and disclosure policies), and prepares audited financial statements meeting prospectus requirements, typically for three years for larger issuers. Many companies also put in place equity incentive plans that meet exchange rules and adopt advance notice and other by-laws.

The long-form prospectus

An IPO uses a long-form prospectus under National Instrument 41-101 General Prospectus Requirements and Form 41-101F1. It describes the business, its risks, its management and their compensation, its capital structure, the use of proceeds, and the plan of distribution, and includes the financial statements and management's discussion and analysis. Mining issuers must also include technical reports under National Instrument 43-101, and oil and gas issuers reserves disclosure under National Instrument 51-101.

Marketing and timetable

A typical Canadian IPO proceeds as follows. The company and its underwriters file a preliminary prospectus, which the regulator reviews over several weeks while the underwriters market the offering to institutional investors through a roadshow, using a standard term sheet and marketing materials that must be filed. Canadian rules permit limited testing-the-waters communications with accredited investors before filing, through investment dealers and subject to confidentiality. Once comments are cleared and the book is built, the price is set, the underwriting agreement signed, and the final prospectus filed and receipted. Closing usually follows within a week, at which point the shares begin trading.

Pricing, allocation and stabilization

Pricing reflects the book built during marketing and the underwriters' advice on aftermarket performance. Underwriters may be granted an over-allotment option, usually up to 15% of the base offering, allowing them to cover short positions created at closing and to support the trading price. Market stabilization activities are permitted within limits under securities rules and CIRO's market integrity rules. Allocation decisions, including any directed share programme for employees or friends of the company, must be handled consistently with the prospectus and conflict-of-interest rules.

Escrow and lock-ups

Shares held by principals of an IPO issuer may be subject to escrow under National Policy 46-201 or exchange escrow rules, releasing over time depending on the issuer's size and exchange. Underwriters also require lock-up agreements from the issuer and major shareholders restricting sales for a negotiated period after the IPO, to support the aftermarket.

Follow-on equity offerings

Once public, issuers use simpler and faster forms of equity offerings. The short-form prospectus system under National Instrument 44-101 allows an issuer with current continuous disclosure filings and listed equity to file a much shorter prospectus that incorporates its annual information form, financial statements, MD&A, circulars and material change reports by reference. Regulator review is completed in a few business days, which makes overnight marketed deals and bought deals possible.

Offering typeHow it worksMain advantageMain consideration
Marketed short-form offeringPreliminary short-form prospectus filed, short marketing period, pricing at finalPrice discoveryMarket risk until pricing
Bought dealUnderwriters commit to buy the whole offering at a fixed price before filingCertainty of proceeds; speedDiscount to market; underwriters' termination rights
Shelf takedownBase shelf prospectus valid for 25 months; prospectus supplements for each offeringFlexibility to raise when windows openRequires maintaining eligibility
At-the-market (ATM) programmeShares sold gradually into the market through an agent under a shelfLow market impact; raise as neededSmaller amounts; ongoing disclosure discipline
Rights offeringRights distributed to existing shareholders to buy new sharesFair to existing holdersLonger timetable; standby commitments often needed

In a bought deal, the underwriters agree to buy the shares at a fixed price, the deal is announced, and the issuer must file a preliminary short-form prospectus within four business days. The underwriters then resell the shares and the offering closes after the final prospectus is receipted. Bought deals give issuers certainty but shift market risk to the underwriters, who price that risk into the discount and negotiate termination rights for market disruption, material adverse change and disaster events.

At-the-market programmes allow an issuer with a base shelf prospectus to sell shares from time to time through an agent at prevailing market prices. Amendments to National Instrument 44-102 in 2022 made ATM programmes available without the exemptive relief previously required, and they have become common for mining and technology issuers that want to raise smaller amounts when liquidity allows.

Disclosure, liability and due diligence

Canadian securities statutes give purchasers under a prospectus a right of action for damages or rescission if the prospectus contains a misrepresentation, without needing to prove that they relied on it. In Ontario this is s. 130 of the Securities Act; other provinces have equivalent provisions. The issuer and selling securityholders have no due diligence defence, but directors, officers who sign, underwriters and experts can avoid liability by showing they conducted a reasonable investigation and had no reasonable grounds to believe there was a misrepresentation. Damages against underwriters are capped at the portion of the offering they underwrote.

Purchasers also have a right to withdraw from an agreement to buy within two business days after receiving the prospectus. After closing, the issuer's continuous disclosure is subject to secondary-market civil liability under Part XXIII.1 of the Ontario Securities Act and its equivalents, which applies to documents incorporated by reference in short-form prospectuses as well.

Due diligence in Canadian equity offerings therefore follows a structured process: management due diligence sessions with a standard question list, review of material contracts and minute books, auditor comfort letters on financial information, legal opinions, and officers' certificates at closing. For mining issuers, the qualified persons who prepared technical reports provide consents and are subject to expert liability.

Practical point

Treat the continuous disclosure record as part of every offering. In a short-form or shelf offering, the documents incorporated by reference become part of the prospectus, and any misrepresentation in them creates primary-market liability. Clean up stale risk factors, forward-looking information and non-GAAP measures before launching a deal, not during the overnight marketing window.

Forward-looking information and non-GAAP measures

Two disclosure areas attract frequent regulator comments in Canadian equity offerings. Forward-looking information, such as projections, targets and production guidance, is permitted but must have a reasonable basis, be identified as forward-looking, and be accompanied by the material assumptions and risk factors, as required by National Instrument 51-102; future-oriented financial information has additional requirements.

Non-GAAP and other financial measures, such as adjusted EBITDA, must comply with National Instrument 52-112, which requires reconciliation to the most directly comparable measure in the financial statements and prominence no greater than that measure. Issuers that rely heavily on such measures in marketing should expect regulators to scrutinize them during prospectus review.

Secondary offerings by selling shareholders

Equity offerings can also be used by existing shareholders, such as private equity sponsors or founders, to sell down their positions. A sale by a control person is itself a distribution requiring a prospectus or exemption. Secondary offerings are often combined with treasury offerings in an IPO, or run as stand-alone bought deals by the selling holder after the lock-up expires. Selling shareholders share prospectus liability for the securities they sell and are usually asked for representations about their title and authority. Registration rights negotiated before the IPO determine who pays the costs and how quickly a holder can demand an offering.

Cross-border equity offerings

Many Canadian equity offerings include US investors, and many foreign issuers raise money in Canada. The multijurisdictional disclosure system (MJDS) under National Instrument 71-101 allows eligible US issuers to offer securities in Canada using a US registration statement, and eligible Canadian issuers to register offerings in the US on Form F-10 or similar forms using Canadian disclosure documents reviewed by the Canadian regulator. MJDS eligibility depends on factors such as reporting history and the size of the public float.

Canadian issuers that do not use MJDS often sell to US institutional investors through private placements under Rule 144A or Regulation D, alongside the Canadian public offering. Offerings into Europe or Asia follow local private placement rules. On the other side, foreign issuers listing in Canada should consider the Canadian corporate law, tax and governance consequences of becoming a Canadian reporting issuer, including National Instrument 71-102 relief for foreign reporting issuers.

Language is a practical issue. A prospectus for a distribution in Quebec must generally be available in French, which affects timetables and cost, particularly for bought deals where the final prospectus must follow quickly.

Listing and life as a public company

Listing on the TSX or TSXV requires meeting the exchange's original listing requirements, which are published by TMX Group and differ for industrial, technology, mining and oil and gas companies and look at measures such as net tangible assets, revenue, cash flow, working capital, public distribution and management experience. The exchanges also require sponsorship in some cases and review the issuer's management and directors.

After listing, the company must meet continuous disclosure obligations under National Instrument 51-102, certify its filings under National Instrument 52-109, maintain an audit committee under National Instrument 52-110, disclose governance practices under National Instrument 58-101, and comply with exchange rules on share issuances, security-based compensation and shareholder approval. Insiders must report trades within five days under National Instrument 55-104. Dual-class share structures are permitted, but the TSX requires "coattail" protections so that holders of subordinate voting shares can participate in a take-over bid for the multiple voting shares. Our continuous disclosure and securities compliance page explains these obligations.

Alternatives to a traditional IPO include a reverse takeover of a listed shell, a qualifying transaction with a capital pool company on the TSXV, a direct listing, or a merger with a special purpose acquisition corporation. Each has its own exchange rules and disclosure requirements; see our insight on reverse takeovers on the TSX Venture Exchange.

Choosing the right equity offerings strategy

The right route depends on the issuer's stage, the amount needed, market conditions and how much certainty it requires. A company that is not yet public and needs significant capital, a broad shareholder base and liquidity will consider an IPO, accepting the cost and ongoing obligations. A listed company that needs funds quickly with certainty may prefer a bought deal, accepting a discount. A listed company with steady needs and a liquid stock may prefer an ATM programme.

Smaller listed issuers can also consider the listed issuer financing exemption, which allows them to raise the greater of CAD 5 million and 10% of market capitalization, capped at CAD 10 million, in a 12-month period without a prospectus, with dilution limited to 50%.

Illustration: a TSX-listed lithium developer needs CAD 40 million for a feasibility study and early works. Its share price is volatile and the market window may close. It negotiates a bought deal with a syndicate, accepting a discount to the closing price, and files a preliminary short-form prospectus within four business days. Because some purchasers are in Quebec, a French version of the prospectus is prepared in parallel. A concurrent private placement to a strategic investor, made under the accredited investor exemption, completes the financing.

How TRW & Co helps with equity offerings

TRW & Co advises issuers, underwriters, selling shareholders and strategic investors on IPOs and equity offerings in Canada. We plan pre-IPO reorganizations, prepare long-form, short-form and shelf prospectuses, negotiate underwriting and agency agreements, run due diligence, and coordinate cross-border offerings using MJDS or US private placement exemptions. For listed issuers we prepare bought deals, ATM programmes and rights offerings, and help maintain the disclosure record that supports them. We are an independent firm and work with Canadian-licensed counsel for filings that require them. Contact us to discuss an offering. This page is general information, not legal advice.

Frequently asked questions

How long does a Canadian IPO take?

Preparation typically takes several months, covering reorganization, audited financial statements, governance and the long-form prospectus. After filing the preliminary prospectus, regulator review and marketing usually take several weeks before pricing and filing the final prospectus. Closing generally follows within about a week of the final receipt, depending on market conditions and the exchange's approval.

What is a bought deal?

A bought deal is an offering in which underwriters commit to buy the entire offering from the issuer at a fixed price before a prospectus is filed. The issuer must then file a preliminary short-form prospectus within four business days. Issuers get certainty and speed; underwriters take market risk and price it into the discount.

Can a US company offer shares in Canada using US documents?

Yes, if it is eligible for the multijurisdictional disclosure system under NI 71-101. Eligible US issuers can file their US disclosure documents in Canada, with a Canadian wrapper addressing Canadian-specific matters. Ineligible issuers must prepare a Canadian prospectus or rely on prospectus exemptions for sales to Canadian investors.

Who is liable for misrepresentations in a Canadian prospectus?

The issuer, selling securityholders, directors, the CEO and CFO who sign, promoters, underwriters and experts whose reports are included. Purchasers do not need to prove reliance. Everyone except the issuer and selling securityholders can rely on a due diligence defence, and underwriters' liability is capped at the portion of the offering they underwrote.

Are at-the-market offerings allowed in Canada?

Yes. Since 2022 amendments to NI 44-102, issuers with a base shelf prospectus can run at-the-market programmes without the exemptive relief that was previously needed. Shares are sold from time to time through an agent at market prices, with regular reporting of sales.

Sources

  1. OSC: Securities Act (Ontario), s. 130 and Part XXIII.1 (e-Laws)
  2. OSC: NI 41-101 General Prospectus Requirements
  3. OSC: NI 44-102 Shelf Distributions
  4. BCSC: NI 45-106 Prospectus Exemptions (Part 5A listed issuer financing)
  5. TMX Group: Listing on TSX and TSX Venture Exchange

General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.